Human Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]-Evobrutinib

NCT03725072 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Evobrutinib

Sponsor

Merck KGaA, Darmstadt, Germany